These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24040819)

  • 21. Central hypertensive effects of aldosterone.
    Gómez-Sánchez EP
    Front Neuroendocrinol; 1997 Oct; 18(4):440-62. PubMed ID: 9344633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
    Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
    Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues revisited.
    Morris DJ; Latif SA; Brem AS
    Steroids; 2009 Jan; 74(1):1-6. PubMed ID: 19013186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mineralocorticoid receptor knockout mice: lessons on Na+ metabolism.
    Berger S; Bleich M; Schmid W; Greger R; Schütz G
    Kidney Int; 2000 Apr; 57(4):1295-8. PubMed ID: 10760057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mineralocorticoid receptors in the pathophysiology of chronic kidney diseases and the metabolic syndrome.
    Shibata S; Fujita T
    Mol Cell Endocrinol; 2012 Mar; 350(2):273-80. PubMed ID: 21820485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steroids, hypertension and cardiac fibrosis.
    Funder JW
    Blood Press Suppl; 1995; 2():39-42. PubMed ID: 7582072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mineralocorticoid receptors in the metabolic syndrome.
    Zennaro MC; Caprio M; Fève B
    Trends Endocrinol Metab; 2009 Nov; 20(9):444-51. PubMed ID: 19800255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M; Fujita T
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mineralocorticoid receptor].
    Nishiyama A; Kiyomoto H; Kohno M
    Nihon Rinsho; 2009 Apr; 67(4):695-700. PubMed ID: 19348230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aldosterone action: fact, failure and the future.
    Funder JW
    Clin Exp Pharmacol Physiol Suppl; 1998 Nov; 25():S47-50. PubMed ID: 9809192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldosterone and its mechanism of action: more questions than answers.
    Fuller PJ
    Aust N Z J Med; 1995 Dec; 25(6):800-7. PubMed ID: 8770356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues.
    Sharma KK; Lindqvist A; Zhou XJ; Auchus RJ; Penning TM; Andersson S
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):79-86. PubMed ID: 16337083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors?
    Chai W; Hofland J; Jansen PM; Garrelds IM; de Vries R; van den Bogaerdt AJ; Feelders RA; de Jong FH; Danser AH
    J Hypertens; 2010 May; 28(5):1044-53. PubMed ID: 20179635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mineralocorticoid receptors in the central nervous system.
    Funder JW
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):179-83. PubMed ID: 8603039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor-knockout mice.
    Haseroth K; Gerdes D; Berger S; Feuring M; Günther A; Herbst C; Christ M; Wehling M
    Biochem Biophys Res Commun; 1999 Dec; 266(1):257-61. PubMed ID: 10581199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and role of aldosterone receptors in the cardiovascular system.
    Lombès M; Farman N; Bonvalet JP; Zennaro MC
    Ann Endocrinol (Paris); 2000 Feb; 61(1):41-6. PubMed ID: 10790591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortisol resistance in conditions such as asthma and the involvement of 11beta-HSD-2: a hypothesis.
    Pretorius E; Wallner B; Marx J
    Horm Metab Res; 2006 Jun; 38(6):368-76. PubMed ID: 16823718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mineralocorticoid receptor binding, structure and function.
    Rogerson FM; Brennan FE; Fuller PJ
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):203-12. PubMed ID: 15134819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural determinants of ligand binding to the mineralocorticoid receptor.
    Huyet J; Pinon GM; Fay MR; Rafestin-Oblin ME; Fagart J
    Mol Cell Endocrinol; 2012 Mar; 350(2):187-95. PubMed ID: 21820032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-function relationships in the mineralocorticoid receptor.
    Pippal JB; Fuller PJ
    J Mol Endocrinol; 2008 Dec; 41(6):405-13. PubMed ID: 18805937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.